CanBas Co.,Ltd. (4575) Other
Market cap
¥14.8B
P/E ratio
Canvas is a biotech company that discovers and develops cancer drugs using its proprietary platform, from early research through clinical trials.
| 2011/06 | 2012/06 | 2013/06 | 2014/06 | 2015/06 | 2016/06 | 2017/06 | 2018/06 | 2019/06 | 2020/06 | 2021/06 | 2022/06 | 2023/06 | 2024/06 | 2025/06 | |
| Return on Assets | - | - | - | - | -38.3 | -9.4 | -14 | -17.9 | -15.2 | -15.7 | -11.7 | -26 | -37 | -29 | -11.9 |
| Return on equity (%) | - | - | - | ||||||||||||
| Employees | 17 | 16 | 15 | 12 | 12 | 13 | 10 | 13 | 13 | 11 | 12 | 11 | 12 | 11 | 14 |